Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:53 pm Sale | 2026-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III, L.P. | 4,556,952 7.400% | -352,667 (-7.18%) | Filing History |
| 2026-08-14 4:10 pm Sale | 2026-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | VIKING GLOBAL INVESTORS LP | 1,503,478 2.500% | -1,163,212 (-43.62%) | Filing History |
| 2026-08-14 08:04 am Purchase | 2026-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | RTW Investments, LP | 3,139,030 5.200% | 1,080,882 (+52.52%) | Filing History |
| 2026-08-12 5:40 pm Purchase | 2026-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Capital World Investors | 3,401,639 5.600% | 3,401,639 (New Position) | Filing History |
| 2026-07-01 9:30 pm Purchase | 2026-07-01 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 14,572,917 19.500% | 907,837 (+6.64%) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | ORUKA THERAPEUTICS INC ORKA | VIKING GLOBAL INVESTORS LP | 2,666,690 5.300% | 0 (Unchanged) | Filing History |
| 2026-05-04 6:00 pm Purchase | 2026-04-30 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 13,665,080 19.990% | 2,502,339 (+22.42%) | Filing History |
| 2026-03-27 11:04 am Sale | 2026-03-13 | 13G | ORUKA THERAPEUTICS INC ORKA | VANGUARD GROUP INC | 0 0.000% | -2,453,530 (Position Closed) | Filing History |
| 2026-02-17 08:39 am Purchase | 2025-12-31 | 13G | ORUKA THERAPEUTICS INC ORKA | RTW Investments, LP | 2,058,148 4.300% | 112,499 (+5.78%) | Filing History |
| 2026-02-13 08:50 am Purchase | 2025-12-31 | 13G | ORUKA THERAPEUTICS INC ORKA | Deep Track Capital, LP | 2,161,510 4.470% | 264,730 (+13.96%) | Filing History |
| 2026-01-30 2:20 pm Purchase | 2025-12-31 | 13G | ORUKA THERAPEUTICS INC ORKA | VANGUARD GROUP INC | 2,453,530 5.060% | 2,453,530 (New Position) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ORUKA THERAPEUTICS INC ORKA | BlackRock, Inc. BLK | 3,175,483 6.600% | 977,966 (+44.50%) | Filing History |
| 2025-11-14 5:35 pm Purchase | 2025-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III, L.P. | 4,909,619 9.900% | 761,191 (+18.35%) | Filing History |
| 2025-10-17 6:41 pm Purchase | 2025-09-30 | 13G | ORUKA THERAPEUTICS INC ORKA | BlackRock, Inc. BLK | 2,197,517 4.500% | 208,637 (+10.49%) | Filing History |
| 2025-09-24 5:11 pm Purchase | 2025-09-17 | 13G | ORUKA THERAPEUTICS INC ORKA | VIKING GLOBAL INVESTORS LP | 2,666,690 5.500% | 2,666,690 (New Position) | Filing History |
| 2025-09-19 6:56 pm Purchase | 2025-09-17 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 11,162,741 19.990% | 2,650,917 (+31.14%) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | BlackRock, Inc. BLK | 1,988,880 5.300% | 1,988,880 (New Position) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | ORUKA THERAPEUTICS INC ORKA | RTW Investments, LP | 1,945,649 5.200% | 1,945,649 (New Position) | Filing History |
| 2025-05-13 4:32 pm Purchase | 2025-05-06 | 13G | ORUKA THERAPEUTICS INC ORKA | Deep Track Capital, LP | 1,896,780 5.070% | 1,896,780 (New Position) | Filing History |
| 2025-03-10 7:00 pm Purchase | 2025-03-06 | 13D | ORUKA THERAPEUTICS INC ORKA | Fairmount Funds Management LLC | 8,511,824 19.990% | 570,134 (+7.18%) | Filing History |